{
  "case_id": "MN20-32868",
  "year": 2020,
  "patient_info": {
    "age_range": "41 to 50",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [
    "malar rash",
    "joint pain",
    "pain",
    "chills",
    "nausea"
  ],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Biologics",
  "treatments_requested": [
    {
      "name": "Benlysta",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "200 milligrams weekly"
    }
  ],
  "treatments_tried_but_failed": [
    {
      "name": "Prednisone",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Methylprednisolone",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Gabapentin",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Hydroxychloroquine",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": "Developed rash after 10 years of use"
    }
  ],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": false,
  "guidelines_details": "FDA approved Benlysta for autoantibody positive SLE, excluding renal and CNS disease. Useful in joint and skin disease.",
  "soc_support": true,
  "soc_not_support": false,
  "soc_details": "Benlysta is added to standard medication such as Plaquenil or steroids. Steroids not effective for chronic management.",
  "study_support": null,
  "study_details": [],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": true,
  "rationale": "The requested service is medically necessary for the treatment of the enrollee\u2019s medical condition. Benlysta is appropriate given the patient's symptoms and lack of response to other treatments.",
  "reviewer_credentials": "Board certified in rheumatology, actively practicing, expert in treating SLE."
}